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MinireviewHIV-1 Sequence Variation:
Drift, Shift, and Attenuation
that there is an exponentially growing population size
(Peeters and Sharp, 2000) and highlights the evolution-
ary “success” of HIV-1 in humans.
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is recombination. This can occur when a cell that isPhiladelphia, Pennsylvania 19104
dually infected with different viruses produces progeny‡Division of Human Biology
virions with genomic RNAs from each virus, and strand-Fred Hutchinson Cancer Research Center
switching takes place during the next round of reverseSeattle, Washington 98109
transcription (Figure 1b). As increasing numbers of full-
length viral sequences become available, the number
of recombinant or mosaic viruses that are formed in this
The introduction and global dissemination of the retrovi- way from parental viruses of different subtypes is being
rus human immunodeficiency virus type-1 (HIV-1) in hu- recognized more frequently. Some of these recombinant
mans represents a dramatic and deadly example of re- genomes have themselves become established in the
cent genome emergence and expansion; since the human population, and are classified as circulating re-
beginning of the pandemic, over 50 million people have combinant forms (CRFs) (McCutchan, 2000; Peeters and
been infected and over 16 million of those have died Sharp, 2000). Importantly, and unlike the incremental
of AIDS. As with all RNA viruses, HIV-1 replication is accumulation of sequence changes that occurs through
characterized by very high mutation rates. Technical copying errors, recombination has the potential to intro-
advances made in DNA sequencing and the recovery duce large numbers of genetic changes simultaneously.
of rare nucleic acids from diverse sources have facili- We liken these two modes of achieving diversification
tated the sequencing of HIV-1 on a massive scale. These to the processes of antigenic drift and antigenic shift that
studies have revealed the remarkable genome plasticity have been described for another RNA virus, influenza A
and continuing diversification of HIV-1 strains; the signif- virus. In this classical example of virus sequence varia-
icance of this diversity for viral pathogenesis remains a tion, copying errors during genome replication result in
major question in the field. minor sequence changes (antigenic drift), and reassort-
The replication of HIV-1, like that of all retroviruses, ment of whole genome segments (the influenza genome
involves reverse transcription of the viral genome into comprises eight distinct segments) following coinfec-
a DNA copy that integrates into the host cell genome. tion with different viral serotypes yields viruses with
As with other viral RNA replicases, reverse tran- novel segment combinations (antigenic shift). One fun-
scriptases lack proofreading capabilities owing to the damental difference between the influenza A virus and
absence of 39!59 exonuclease activity. In the case of the HIV-1 subtype nomenclature is that influenza A sub-
HIV-1, the misincorporation, deletion, insertion, or dupli- types correspond to virus phenotype (antigenicity) while
cation of nucleotides occurs during reverse transcrip- assignment to an HIV-1 subtype is based on nucleotide
tion with a frequency of 1024 to 1025. This error fre- sequence alone.
quency, coupled with an in vivo virus production rate Different clades and CRFs are unequally distributed
exceeding 109 per day in an individual, the large number across the globe; for instance, subtype B dominates
of infected people, and the persistent nature of infec- North America and Europe whereas A, C, and A/G re-
tions, provides HIV-1 with tremendous scope for the combinants are the most prevalent subtypes in Africa.
generation of viral diversity (Figure 1a). For instance, A major question is whether HIV-1 subtypes segregate
circulating HIV-1 strains are continuing to diversify at with any particular biological properties. Differences in
about 0.0024 substitutions per base pair per year host genetics (Rowland-Jones et al., 2001 [this issue
of Cell]) and epidemiology within and between cohorts(Korber et al., 2000), a rate that is five to six orders of
make the analyses of subtype-specific variations in viralmagnitude greater than for mammalian gene families.
phenotypes extremely difficult to sort out. Accordingly,Three distinct groups of HIV-1, called M (main), O
evidence for biological differences between HIV-1 sub-(outlier), and N (non-M, non-O), have been identified
types is scant, but nevertheless intriguing. For example,and likely represent the products of three independent
in one cohort where subtypes A, C, D, and G were allcross-species transmissions of a simian immunodefi-
present, people infected with C strains had statisticallyciency virus that resides in chimpanzees (SIVCPZ) into
lower CD4 T cell counts and higher viral loads (Neilsonhuman populations (Hahn et al., 2000). Phylogenetic
et al., 1999). Also, initial studies linked the presenceanalyses further divide the M group, which make up the
of an additional NF-kB site in subtype C promoters tovast majority of circulating strains, into nine subtypes
enhanced transcription and responsiveness to tumor(A, B, C, D, F, G, H, J, and K) that are about 25% to 30%
necrosis factor-a in vitro, and, possibly, to increaseddifferent from each other and share a single common
replication in patients with chronic immune system acti-ancestor that has been dated at around 1930 (1915–
vation. However, recent extensive sequencing efforts1941) (Korber et al., 2000). The “star-burst” phylogeny
have shown that this extra site is only found in a minorityof the M group strains from this postulated root suggests
of subtype C viruses (Rodenburg et al., 2001), thus high-
lighting the need to use multiple sequences to formulate
hypotheses regarding any possible subtype-specific§ E-mail: malim@mail.med.upenn.edu, memerman@fhcrc.org
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Figure 1. Modes of HIV-1 Sequence Diversi-
fication
The crosses signify copying errors made dur-
ing reverse transcription, while red and blue
proviruses represent phylogenetically dis-
tinct virus strains. Refer to the text for further
details.
biology. HIV-1 and HIV-2 differ from one another in terms quency of recombinants in cohorts where multiple
clades are present has been estimated to be aroundof pathogenicity, and by z50% in nucleotide sequence.
Although an imperfect comparison for HIV-1 subtype 20% (Neilson et al., 1999). This level of abundance, to-
gether with indications that CRFs can replace existingdifferences, such differences do point out the potential
for biological variation between human lentivirus infec- subtypes in some populations (for example, a subtype
A/G recombinant has become the predominant straintions and disease progression.
Genetic Shift in parts of western and central Africa), suggests that
certain recombinants may be able to spread faster thanThere is ample evidence that genetic shift between re-
troviruses has occurred in ways that have helped shape their parent subtypes (McCutchan, 2000). Although the
supplanting of one viral subtype with another withinthe evolutionary history of viral populations. For in-
stance, the SIV that infects the sabaeus species of Afri- a study population must be interpreted with caution
because of the possible influence of “founder” effects,can green monkeys in west Africa (SIVAGM/SAB) is actually
a complex recombinant between diverse SIV lineages studying phenotypic variations between recombinants
and their matching parental strains offers opportunitiesfound in different genera of African monkeys (Hahn et
al., 2000). This phenomenon is not unique to members to address determinants of altered pathogenicity or
transmission. For example, an HIV-1 A/B recombinantof the lentiviral genus of retroviruses, and is not even
restricted to viruses that normally infect similar animal that is responsible for a rapid epidemic among intrave-
nous drug users in Kaliningrad (Russia) is a recombinantspecies. For instance, the reticuloendotheliosis virus
family of oncoretroviruses, which infects turkeys, ducks, in the nef gene and could shed some light on the in vivo
significance of the multiple properties that have beenand other gallinaceous birds, has a recombinant ge-
nome that is similar to murine retroviruses at its 59-end attributed to this gene.
It was once thought that recombination is a relativelyand to a class of primate retroviruses at its 39-end (Kewa-
lramani et al., 1992). Thus, recombination has the poten- rare event since coinfection is limited by a phenomenon
called “super-infection immunity” whereby one retrovi-tial to expand the host range of circulating viruses.
Since recombination between different retroviruses rus generally precludes subsequent infection by a sec-
ond retrovirus due to downregulation of the viral recep-requires a common host, one can use the existence of
recombinants as evidence that dual infections must tor. However, recent data suggests that coinfection of
cells with HIV-1 may be common in vivo (Gratton et al.,have occurred. For example, the N group of HIV-1 (which
has only been found in Cameroon) is a mosaic formed 2000). Thus, within a single host, recombination could
be a major force for the rapid dissemination of multi-between divergent viral lineages most closely related to
HIV-1 and SIVCPZ. For coinfection of chimpanzees by the drug resistance (see below), or for the redistribution of
viral genes under selection pressure on the backboneN group parental strains to have occurred, these two
ancestral viruses must have had overlapping patterns of of an already drug-resistant genome (Figure 1c).
Diversity during Disease Progressiongeographic distribution and a degree of shared tropism.
Such lines of reasoning further support the argument High viral loads and host cell turnover characterize HIV-1
infection. Accordingly, the virus replicates as a hetero-that HIV-1 comprises viral lineages that are part of a
larger family of viruses found in chimpanzees, and is, geneous and dynamic mixture of sequence variants,
called a quasispecies, that continues to evolve for thetherefore, the product of SIVCPZ zoonoses (Hahn et al.,
2000). Notably, there is still no direct evidence that these duration of an infection. While the rate and extent of
diversification differs from one infected person to theancient recombination events conferred advantageous
phenotypes other than the prevalence of the strains next, a recent longitudinal analysis of env gene variation
determined that divergence from the founder (transmit-themselves.
With the HIV-1 M group viruses, recombination pro- ted) strain, as well as overall diversity, both increased
by z1% per year in the early phases of typical infectionsvides a major mechanism for generating “new” viruses
and is occurring in “real-time.” Specifically, the fre- (Shankarappa et al., 1999). At any given time, viral popu-
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lations will be dominated by those strains that are most ural transmission may select against overt virulence
(Ebert, 1998). For example, it is well documented thatfit at that time. Because the selective pressures that
determine which viral attributes confer fitness are con- new transmissions reestablish the selection for R5 vi-
ruses even if the index case contained both X4 andstantly changing, the continual generation of diversity
is presumably important for viral persistence in the in- R5 viruses. Our current understanding of virulence and
transmission is very incomplete, so it is likely that otherfected host. This being said, the relative contributions
of selection versus stochastic processes in driving virus viral determinants are also selected for or against during
natural transmission. In addition, HIV-1 transmission isdiversification remain controversial and unresolved (Cran-
dall et al., 1999). an inefficient process; for instance, less than 1% of
heterosexual exposures result in successful transmis-One area of current uncertainty is whether disease
progression is accompanied by the emergence of strains sion. This argues that few viral particles are capable of
establishing a new infection. It is possible, therefore,that are more pathogenic. Using the SIV/macaque experi-
mental model for primate immunodeficiency virus infec- that such transmission selects for particular strains that
would constitute only a minority fraction of the challengetions, a number of studies have shown that serial pas-
sage of SIV (and HIV/SIV chimeras) from one animal to inoculum and may be relatively less fit in the context of
an established infection.the next generates viruses that replicate with increased
titers and/or display heightened virulence. In a related A key selective pressure that helps propel viral diver-
sity during the course of a single infection is evasion ofstudy, monkeys were challenged with cloned SIVs iso-
lated during the early, mid, and late stages of an experi- the host immune response. Studies using the SIV system
indicate that the virus continually adapts to evade themental infection; again, the late-stage virus grew to
higher titers and induced more rapid progression to an inhibitory action of neutralizing antibodies. That the hu-
moral response helps to control SIV replication is furtherAIDS-like disease (Kimata et al., 1999).
Many analyses have demonstrated that HIV-1 tropism supported by the noted inverse correlations between
viral virulence and sensitivity to neutralizing antibodies.evolves during infection: transmitted (early) strains uti-
lize the CCR5 chemokine receptor for viral entry (R5 For HIV-1, the evidence for the development of effective
neutralizing antibodies during infection is much lessviruses), whereas many late-stage strains utilize CXCR4
instead (X4 viruses). However, while the appearance convincing. Indeed, it has been argued that viral escape
from such ineffective responses may be relatively insig-of X4 viruses frequently correlates with faster disease
progression, it remains unclear whether this phenotypic nificant compared to other selective processes, or that
it may even be a byproduct of viral variation (Parren etswitch is a cause or a consequence of immune system
dysfunction. Moreover, the switch is not observed in all al., 1999).
Though it has become clear that cytotoxic T lympho-patients who progress to AIDS and is rare in people
infected with subtype C viruses (McCutchan, 2000). It cytes (CTLs) play the predominant role in virus clearance
during the acute phase of HIV-1/SIV infections, a defini-has frequently been suggested that X4 viruses are more
fit than R5 viruses; in particular, single strain challenges tive demonstration of CTL escape through sequence
variation has been obtained only recently. Using thein culture often show that X4 viruses replicate more
rapidly and with greater cytopathicity. Recent studies, SIV model, Allen and colleagues (2000) measured CTL
responses and sequenced circulating viruses for eighthowever, have begun to address the question of fitness
by systematically evaluating replicative capacity by weeks following challenge. Importantly, the diminution
of a strong CTL response against a Tat-specific epitopechallenging cultures with mixtures of viruses and de-
termining the “winner” strain over time (Quinones-Mateu was accompanied by frequent changes in the corre-
sponding region of the tat gene (82% of clones wereet al., 2000). A number of interesting findings are emerg-
ing: (1) there is no evident correlation between replica- altered by eight weeks post-infection). Further analysis
of these samples also revealed that increased rates oftion fitness in vitro and the R5/X4 phenotype; (2) there
is a correlation between fitness in culture and viral load sequence variation in this epitope were correlative with
lower viral loads, a conclusion that is consistent within vivo; and (3) patients who are long-term survivors
tend to be infected with viruses that are intrinsically an earlier longitudinal study of HIV-1 infected subjects
where increased rates of diversification tended to corre-less fit in culture. It will now be instructive to use this
competition approach to assess whether (or how) repli- late with slower disease progression (Wolinsky et al.,
1996). In sum, these findings suggest that while CTLcative capacity changes during the course of HIV-1 in-
fection. escape and increased viral diversity may be necessary
for averting virus elimination, such changes may cost theIn contrast to the observations made with SIV models
(cited above), there is no evidence that HIV-1 increases virus in terms of replicative potential by compromising
important viral functions.in virulence as it is transmitted from one person to the
next. What, then, are the possible explanations for the One unambiguous illustration of HIV-1’s capacity to
adapt in response to selection is the emergence of drug-dichotomy between experimental SIV infections and
natural HIV-1 infections in terms of the relationship be- resistant strains in patients receiving antiretroviral ther-
apy. For example, treatment of HIV-1 infected peopletween virus diversity and pathogenicity? The answer
most likely relates to the process of transmission where with single inhibitors of viral enzymes typically selects
for resistant strains that predominate within weeks of theselection pressures differ from those encountered within
a single infected host. In serial passage experiments, initiation of therapy. Even though combination therapies
using multiple reverse transcriptase and protease inhibi-such as those discussed for SIV, the use of bulk inocula
containing multiple strains usually results in the rapid tors commonly suppress virus replication for prolonged
periods, multi-drug resistant strains can evolve duringselection of viruses with augmented virulence, while nat-
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S., Nduati, R.W., Mbori-Ngacha, D., Panteleeff, D.D., Bodrug, S., ettion due to the high mutation rate of the virus. In an
al. (1999). J. Virol. 73, 4393–4403.infected person with high viral burden, such viruses would
Parren, P.W., Moore, J.P., Burton, D.R., and Sattentau, Q.J. (1999).normally be out-competed by the descendents of vi-
AIDS 13, S137–S162.ruses with greater fitness. However, attenuated viruses
Peeters, M., and Sharp, P.M. (2000). AIDS 14, S129–S140.could occasionally become fixed if the virus passes
Quinones-Mateu, M.E., Ball, S.C., Marozsan, A.J., Torre, V.S., Al-through an extreme “bottleneck” as low numbers of
bright, J.L., Vanham, G., van Der Groen, G., Colebunders, R.L., andinfectious particles establish new transmissions (Duarte
Arts, E.J. (2000). J. Virol. 74, 9222–9233.
et al., 1992). Studies of HIV-1 infected people who prog-
Rodenburg, C.M., Li, Y., Trask, S.A., Chen, Y.J., Robertson, D.L.,ress to disease very slowly or not at all (called long-
Kalish, M.L., Shaw, G.M., Allen, S., Hahn, B.H., Gao, F., et al. (2001).
term nonprogressors or survivors) show that a minority AIDS Res. Hum. Retroviruses 17, 161–168.
of these cases are, in fact, attributable to obviously Rowland-Jones, S., Pinheiro, S., and Kaul, R. (2001). Cell 104, this
attenuated viruses. One of the most prominent exam- issue, 473–476.
ples of this is a cohort of transfusion recipients in Sydney Shankarappa, R., Margolick, J.B., Gange, S.J., Rodrigo, A.G., Upch-
who were infected with a virus that lacked an intact urch, D., Farzadegan, H., Gupta, P., Rinaldo, C.R., Learn, G.H., He,
X., et al. (1999). J. Virol. 73, 10489–10502.nef gene before 1985, and who have remained mostly
asymptomatic (Learmont et al., 1999). It is likely that Wolinsky, S.M., Korber, B.T., Neumann, A.U., Daniels, M., Kunstman,
K.J., Whetsell, A.J., Furtado, M.R., Cao, Y., Ho, D.D., and Safrit, J.T.continued analyses of full-length virus sequences will
(1996). Science 272, 537–542.identify additional cases; studying the defects in these
viruses has the potential to be very revealing of viral
functions that are important in vivo.
It is important to reemphasize that viruses do not
necessarily evolve toward greater pathogenicity. In-
deed, the SIVs that naturally infect non-human primates
in Africa discussed above do not cause observable dis-
ease in their natural hosts, yet can clearly induce fatal
diseases when transferred to other species. Since some
of these SIVs have resided in their host species for (at
least) thousands of years, they might be examples of
viruses that have become attenuated for disease in their
natural hosts. There are numerous examples of viruses
that are ubiquitous in the human population that are
usually not pathogenic. Given time, is it possible that
HIV-1 might similarly evolve? In essence, we do not
know if HIV-1 diversification is yielding more, less, or
equally pathogenic strains. Only difficult studies that
combine extensive sequence data, standardized natural
history, and carefully measured biological determinants
will be able to begin to answer this question.
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